Ipsen in the United Kingdom



Biological Manufacturing

Dating back to 1990, the Wrexham facility is dedicated to the production of biological compounds. Dysport® is produced at Wrexham. In addition to the manufacturing of existing drugs and product development, Wrexham also serves as the logistics platform for the UK.




Ipsen’s site in Slough houses a number of the Group’s R&D activities (clinical development, regulatory affairs, pharmacovigilance, etc.). Slough is also the Group’s commercial affiliate in the UK.


Abingdon (Oxford)


This R&D center has an expertise in natural and modified recombinant botulinum toxins, and in targeted secretion inhibitors or retargeted molecules.


Return to the map
See all locations


Updated on 27 February 2013